Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEM OS1 in Foot and Ankle Arthrodesis
2006-004779-36Phase 2Completed
- Sponsor
- BioMimetic Therapeutics
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Augment Bone Graft in Arthrodesis, sponsored by BioMimetic Therapeutics. Primary endpoint: Union rate at 24 weeks. Started Oct 2006; status: completed.
02
Drugs
Augment Bone Graft
03
Conditions
Arthrodesis
Beyond the preview
Go deeper on 2006-004779-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004779-36.